Murine monoclonal antibodies and polyvalent monospecific antisera reactive with an abundant 68 000 M r (p68) human cytomegalovirus (CMV) virion protein were used to characterize this protein within CMV-infected cells. The protein was found to partition within the nucleus and cytoplasm of infected cells. Pulse-chase analysis indicated the p68 was degraded into three proteins of 52000, 51000 and 50000 Mr which were found only within infected cells. Both cellular forms as well as the virion p68 were phosphorylated but non-glycosylated. The p68 was synthesized shortly after infection and in the presence of cytosine arabinoside, an inhibitor of viral DNA replication. Studies with monospecific antisera and a panel of monoclonal antibodies specific for the p68 suggested that this protein was not expressed on the surface of infectious virions or infected cells.
INTRODUCTION
Human cytomegalovirus (CMV) is a well documented cause of significant morbidity and mortality in immunocompromised hosts (Ho, 1982) . In addition, CMV is the most common cause of congenital viral infections (Alford et al., 1980) . Although the immune response to CMV clearly plays an important role in limiting the severity of CMV-induced disease, little is known about the nature of the host response to CMV, especially in terms of the virus-encoded, antigenic targets of the host response. Several recent reports have demonstrated both humoral and cellular immune responses to an abundant 66000 to 68000 M r virion protein (Pereira et al., 1982a; Forman et al., 1985; Zaia et al., 1986) . Although this protein has been characterized in several reports, there remains some uncertainty as to its location within the virion and infected cell. A recent report suggested that an abundant virion 68 000 Mr glycoprotein (p68) was expressed on the surface of both infectious virions and infected ceils (Pereira et al., 1982b) . In contrast to this report, other investigators have suggested this protein was non-glycosylated and could not be detected on the surface of virions (Gibson & Irmiere, 1984; Kim et al., 1983) . Furthermore, another study has suggested that p68 is found predominantly within the nucleus of infected cells (Weiner et al., 1985) . Several explanations could account for these apparently discrepant findings. Because panels of monoclonal antibodies used in those studies may have contained antibodies reactive only with internal epitopes of p68, the failure to demonstrate its surface expression may have been an artefact. Alternatively, different investigators may have characterized structurally and antigenically unique proteins which comigrated in SDS-PAGE. In support of this hypothesis, we have recently described a 62000 MT broadly migrating virion envelope protein which comigrated with the p68 in 10~ acrylamide gels (Britt & Auger, 1985) . These two proteins could, however, be readily resolved by electrophoresis in lower concentration acrylamide gels. Because immunological recognition of p68 would require surface expression either on infected cells or virions, it would seem important to resolve these discrepant findings. In this report we have characterized the intracellular forms of p68 using a group of monoclonal antibodies. These monoclonal antibodies have also been shown to react with the 66000 Mr virion protein described by Clark et al. (1984; J. Zaia, personal communication) . In 0000-7530 O 1987 SGM addition, we have used heterologous, monospecific antisera generated by immunization of mice with purified p68 to characterize the surface expression of this protein. Our results suggested the p68 was an internal, non-glycosylated virion phosphoprotein which was inaccessible in virions or on the surface of infected cells to anti-p68 antibodies. Furthermore, in contrast to other virion structural proteins, the p68 was synthesized within 3 to 4 h following infection, prior to viral DNA replication.
METHODS
Virus and cells. CMV strain ADI69 was used for all experiments. Human fibroblast (HF) cells were obtained from newborn foreskin cultures as described by Britt & Auger (1986a) . Virus and cells were passaged as described by Britt & Auger (1986a) .
Plaque reduction assays. These have been described in detail in an earlier publication (Britt, 1984) . Monoclonalantibody production. The production of the murine monoclonal antibodies used in this study has been detailed in an earlier publication (Britt, 1984) . All antibodies were CMV-specific in that they failed to react with uninfected HF cells or HF cells infected with either varicella-zoster virus or herpes simplex virus.
Membrane immunofluorescence. HF cells were grown on glass coverslips (13 mm diam.) and infected with AD169. Five days following infection, the coverslips were reacted with tissue culture supernatant containing monoclonal antibodies or monospecific mouse sera diluted 1/50 or 1/100 for 60 m in. Following washing, specific binding was detected with a fluorescein-coupled goat anti-mouse immunoglobulin antibody (Tago. Burlingame, Ca., U,S.A.).
lmmune precipitation, SDS-PAGE and immunoblotting. Both of these assays have been described in detail in previous publications (Britt & Auger, 1986a) . All acrylamide gels were 7.5 o/. Molecular weights were estimated by comparing migrations with known molecular weight standards (Sigma).
Radiolabelling ofvirions and infected cellproteins. Infected cells (5 days post-infection unless otherwise specified)
were radiolabelled with [35S]methionine (30 ~tCi/ml), 32p, (50 laCi/ml) or [3H]glucosamine (50 pCi/ml) for 6 h under conditions previously described (Britt & Auger, 1986a) . Extracellular virions were collected by centrifugation of clarified supernatants from radiolabelled infected cell cultures through 20 to 70% linear sorbitol gradients as described by Britt (1984) . Nuclear and cytoplasmic fractions were prepared by treating infected cells with 0.l~ Nonidet P40 (NP40) in 0-05 M-Tris HC1, 0.15 M-NaC1, 0.001 M-EDTA, pH 7.35 (TBS) for 10 min at 4 °C. Following centrifugation at 1000 g, the soluble fraction (cytoplasmic) was removed and the nuclear pellet was washed once with 0.1 ~ NP40-TBS. The nuclear pellet was then solubilized in 0.5 M-NaC1 containing 1% SDS. The solubilized proteins in both fractions were diluted tenfold with TBS containing 0.1% SDS, 1% deoxycholate and 1 ~ NP40 and immune-precipitated with monoclonal antibodies 28-19, 28-21 or 7-17 as described.
Pulse chase analysis. Individual cultures of HF cells infected 5 days previously with AD169 were pulse-labelled with [35S]methionine (30 ~tCi/ml) for 10 min, washed and chased in medium containing unlabelled methionine. The chase periods were terminated by removal of the medium and freezing of the entire culture at -70 °C. Infected cell proteins were solubilized as described above and precipitated by antibody 28-19.
Partialproteolyticpeptide mapping. HF cells were infected 5 days previously with AD169 and then labelled for 18 h in medium containing [35S]methionine (50 IxCi/ml). After disruption, the infected cell proteins were precipitated with antibody 28-19 and separated by SDS-PAGE. The p68, 52, 51 and 50 were visualized by autoradiography and gel slices containing the respective proteins were removed and placed in the wells of a second polyacrylamide gel. Staphylococcal V8 protease (Miles Laboratories) was added at concentrations of 0.05, 0.5 and 5 ~tg to individual wells. The proteins were then electrophoresed until the tracking dye reached the interface between the stacking and resolving gels, the power was turned off and enzymic digestion was allowed to proceed for 45 rain. Following digestion, the peptides were electrophoretically separated and visualized as described by Britt & Auger (1986a) . Individual cultures were radiolabelled with [3sS]methionine (30 ~tCi/ml) at 3, 7 and 23 h post-infection. Labelling was terminated 1 h later by removal of the medium and freezing at -70 °C. The infected cell proteins were solubilized as described above and precipitated with antibody 28-19 or 28-21. Radiolabelling in the presence of cytosine arabinoside was accomplished by infection of HF cells with AD169 (m.o.i. 4) in the presence of 100 ~tg/ml of cytosine arabinoside (Sigma). Following a 16 h incubation period, the medium was removed and replaced with [35S]methionine plus cytosine arabinoside for 1 h. The labelling was terminated as above.
Production ofmonospec~'c antisera in mice. Infected cell p68 was precipitated by antibody 28-19 and purified by SDS-PAGE as described by Britt & Auger (1986b) . Briefly, p68 was immune-precipitated from a preparation of infected cell proteins by antibody 28-103, separated by SDS-PAGE and identified by Coomassie Brilliant Blue staining. The gel band containing the protein was incubated in TBS containing 1% SDS, 1% 2-mercaptoethanol at 37 °C for 6 h. The protein in the supernatant was precipitated with 4 vol. acetone. Four adult BALB/c mice were immunized subcutaneously with 10 ~tg of p68 emulsified in complete Freund's adjuvant. Two weeks later, the mice were injected subcutaneously with 10 ~tg of p68 in incomplete Freund's adjuvant. Three weeks following this boost, animals were again given an identical boosting dose. One week following the final boost, the mice were sacrificed and exsanguinated.
RESULTS

Monoclonal antibodies reactive with the virion p68 detect four immunologically and structurally related proteins within infected cells
The intracellular forms of the virion p68 were initially examined by immunoblot analysis because our previous findings indicated that this protein was incompletely solubilized in the detergents utilized to prepare infected cell proteins for immune precipitation reactions. Infected cell proteins were divided into nuclear and cytoplasmic enriched fractions by solubilization in non-ionic detergents and low speed centrifugation. Extracellular virions from these cultures were collected by centrifugation through sorbitol gradients (Britt & Auger, 1986a) . Following electrophoretic separation of the virion and infected cell proteins, the proteins were transferred to nitrocellulose membranes and probed with antibody 28-19. Antibody 28-19 reacted with p68 which was found in virions and both the nuclear and cytoplasmic fractions of infected cells (Fig.  1 ). In addition, antibody 28-19 detected a more rapidly migrating species of approximate Mr 50000 in both the nuclear and cytoplasmic fraction (Fig. 1 ). These results indicated that the mature form of the virion p68 was found in both nuclear and cytoplasmic fractions of infected cells and that an antigenically related, more rapidly migrating protein(s) of 50 000 Mr was found only within infected cells.
To investigate further the relationship between these two cross-reactive proteins found within infected cells, we studied the synthesis of the p68 by a pulse-chase analysis. Newly synthesized p68 could be detected in the first 10 min chase interval and continued to accumulate in the following two chase intervals (Fig. 2) . Three closely migrating proteins of estimated Mr 52000 (p52), 51000 (p51) and 50000 (p50) were initially detected in the 20 min chase interval and were also present in the following interval (Fig. 2 ). In the final 40 min chase interval, the quantity of labelled p68 decreased relative to that at earlier intervals, whereas the quantity of p52, p51 and p50 had increased (Fig. 2 ). Similar findings were observed when the chase periods were extended to 6 h, suggesting the p68 was relatively stable within infected cells (data not shown). These results indicated that the 50000 Mr protein described in Fig. 1 most likely consisted of three closely migrating proteins, p52 to p50, which were not resolved by the immunoblot analysis. In addition, the accumulation of these three proteins during chase intervals in which the quantity of newly synthesized p68 was diminishing, suggested these proteins arose by either processing or degradation of the parent p68. To determine the structural relatedness of these infected cell proteins, we carried out limited proteolysis of SDS-PAGE-separated proteins and then compared the peptide profiles by a second SDS-PAGE. We could not adequately resolve the p51 and p50 in our gel systems to allow separate analysis of these proteins; therefore gel slices containing the p5t and p50 proteins were combined. The profile of the mature p68 revealed at least six unique peptides, of which, four comigrating peptides could be found within the peptide profiles of the p51/50 and p52 (Fig. 3) . These results indicated that members of the p52-p50 family of infected cell proteins were structurally related to the mature p68 and further indicated that these proteins arose by processing or degradation of the p68.
The p68 and its intracellular.forms are non-glycosylated phosphoproteins
Several previous studies have provided conflicting results concerning the presence of carbohydrate modifications on an abundant 64000 to 68000 Mr virion protein (Clark et al., 1984; Kim et al., 1983; Pereira et al., 1982b Pereira et al., , 1984 . For this reason, we next investigated the post-translational modifications of the p68. CMV-infected cells were pulse-labelled with [3H]glucosamine for 6 h and the infected cell proteins solubilized, immune-precipitated with antibody 28-19 and analysed by SDS-PAGE. To ensure that the labelling period was sufficient for incorporation of detectable amounts of [3H]glucosamine, we also immune-precipitated the infected cell proteins with antibody 7-17, which is directed against the gp55-116 complex of CMV envelope glycoproteins (Britt & Auger, 1986a) . Even with prolonged exposure of the ftuorogram, we failed to detect labelled p68 or its intracellular forms in this experiment (Fig. 4) . In contrast to this result, we could easily detect the intracellular precursor gpl50 (160) and the mature gp 116 of the gp55-I 16 complex (Fig. 4) . Furthermore, the p68 could not be radiolabeUed with [3H]fucose, [3H]galactose or [3H]galactosamine (data not shown). Finally, radiolabelling infected cell proteins in the presence of tunicamycin or the ionophore monensin did not alter the electrophoretic migration of the p68 or its intracellular forms (data not shown). In contrast to previously published reports, these results would strongly suggest that neither the p68 nor its intracellular forms were glycosylated. However, we could not exclude the possibility that the p68 incorporated undetectable quantities of [3H]glucosamine. Conversely, radiolabelling infected cells with 32p followed by immune precipitation and SDS-PAGE of the cytoplasmic and nuclear enriched fractions and extraceUular virions, revealed that both the virion p68 and the infected cell p68 and p52-50 were phosphorylated (Fig. 5) . Interestingly, the family of p52-50 proteins contained nearly the same amount of radiolabel as the mature p68 (Fig. 5) . Although the explanation of this finding is unclear, a possibility is that these related forms contained the phosphorylation site(s) of the p68. Additional studies will be necessary to clarify this result.
The p68 is synthesized very early after infection and in the absence of viral DNA replication
During our studies using immunofluorescence and immunoblotting with monoclonal antibody 28-19, we noted that nuclear reactivity of infected cells could be detected as early as 2 h post-infection. Because the p68 was an abundant component of the virus, we could not exclude the possibility that antibody reactivity resulted from the presence of input virus. To resolve this question, we investigated the kinetics of synthesis of the p68 by radiolabelling infected cells shortly after infection and analysing the infected cell proteins by immune precipitation and SDS-PAGE. As a control, we also immune-precipitated the infected cell proteins with antibody 28-21 which is reactive with a family of previously described non-structural proteins of Mr 51000, 49000, 40000 and 38000 (Gibson, 1983) . Newly synthesized p68 could be detected as early as 4 h post-infection and increased to near steady state levels by 24 h (Fig. 6) . In contrast to these results, the family of proteins detected by antibody 28-2l could be seen only at 24 h postinfection (Fig. 6 ). This very early synthesis of p68 suggested this protein was synthesized prior to viral DNA replication. To test this possibility we infected HF cells in the presence or absence of cytosine arabinoside (Ara-C), an inhibitor of viral DNA synthesis . Following a 16 h infection period in medium containing Ara-C, the cells were radiolabelled with [3SS]methionine for 1 h in the presence of Ara-C, and the infected cell proteins were precipitated with antibody 28-19 or 28-21. The p68 was synthesized in equivalent amounts regardless of whether Ara-C was present, whereas the most abundant 51000 Mr component of the family of proteins detected by antibody 28-21 could be detected only in the absence of Ara-C (Fig. 6) . These results indicated that synthesis of the p68 began within 4 h following infection and occurred independently of viral DNA replication. Thus, the p68 could be classified as a delayed early or/~ gene product, even though it was a virion structural protein.
The p68 does not induce neutralizing antibodies and is not expressed on the surface of infected cells
As was noted previously, other investigators have suggested that an abundant 68000 Mr virion protein expressed epitopes recognized by neutralizing antibodies and could be detected on the surface of infected cells (Pereira et al., 1982b) . If indeed the CMV-encoded p68 was expressed on the surface of infected cells early in the replicative cycle, prior to release of infectious virions, then an immune response directed against this viral protein might effectively eliminate infected cells prior to release of progeny virus. Initially we investigated the expression of this protein on the surface of infectious virions and infected cells utilizing a panel of 12 independently derived monoclonal antibodies reactive with p68 as determined by immunoblotting. Although the positive control monoclonal antibody 14-9, which is reactive with a 62 000 Mr HCMV envelope protein, neutralized infectious virus and reacted with the surface of infected cells, none of the anti-p68 monoclonal antibodies reacted with the surface of infected cells or exhibited significant neutralizing activity when compared with the control, non-reactive monoclonal antibody 48 (Table 1) . Although these results suggested the p68 was not expressed either on the surface of virions or of infected cells, it was possible that this panel of antibodies was directed only against unexposed, internal epitopes. We examined this question by generating monospecific antisera reactive with the p68. Immune serum was produced by repeatedly immunizing mice with SDS-PAGE-purified p68. Because this polyvalent serum could be expected to react with a larger number of epitopes than the panel of monoclonal antibodies, it was a more useful reagent for determining the surface expression of p68 and its related forms in virions and infected cells. Serum was obtained prior to immunization, 2 weeks after the initial boosting immunization, and at sacrifice after a total of three immunizations. Although the pre-immune sera exhibited some neutralizing activity at low serum dilutions, we could detect no increase in the neutralizing activity of immune sera after a total of three immunizations with purified p68 (Table 1 ). This result suggested that immunization with p68 failed to induce a significant neutralizing antibody response. Likewise, the immune sera did not exhibit cell surface reactivity against CMV-infected cells (Table 1) . To ensure that antibodies reactive with the p68 were produced in response to the immunization procedure, we characterized the reactivity of this serum using the immunoblot assay against CMV virions. Each of the individual sera reacted with the virion p68 (Fig. 7) , indicating that antibodies reactive with this protein were present in these sera. These results supported our findings 0 (0-16) -* Four BALB/c mice were immunized with SDS PAGE-purified p68 as described in Methods. Sera were collected (A) pre-immunization, (B) after the first boost and (C) at sacrifice following the second boost. Neutralizing activity was expressed as plaque reduction at the dilutions indicated. Membrane fluorescence of viable AD169-infected HF cells was assayed as described in Methods.
~f ~rr, Not tested. J; Murine monoclonal antibodies included a neutralizing, anti-virion envelope antibody, 14-9 (Britt & Auger, 1985) , and a control, non-reactive antibody, 48, which is directed against gp70 of Friend murine leukaemia virus (Chesebro et al., 1981) . The anti-p68 monoclonal antibodies included 12 reactive with p68 as determined by immunobloning. All of the anti-p68 antibodies were of the IgG isotype. The neutralizing activity of the anti-p68 monoclonal antibodies was determined as described in Methods and expressed as the median plaque reduction with the range listed within parentheses.
obtained with the panel of monoclonal anti-p68 antibodies as well as confirming a previous report which indicated that anti-p68 monoclonal antibodies failed to neutralize infectious virus (Kim et al., 1983) . In addition, our results indicated that although the p68 and its related forms p52-p50 were abundant infected cell proteins, it was likely these proteins were not expressed on the surface of infected cells.
DISCUSSION
In this report we have characterized the synthesis and expression of an abundant 68000 Mr (p68) structural protein of human CMV. Our results indicated this protein was rapidly synthesized in its mature form and then degraded or, alternatively, processed into three intracellular forms of Mr 52000, 51000 and 50000. The degradation and/or processing of p68 occurred only within infected cells as these more rapidly migrating forms were not detected in mature, extracellular virions. It was unlikely that these more rapidly migrating forms of p68 were an artefact arising from proteolysis of the p68 in vitro as we could not inhibit the breakdown of p68 by adding different protease inhibitors, including phenylmethylsulphonyl fluoride to our cell lysis buffers. In addition, the fnding of the more rapidly migrating forms in the immunoblot analysis argued strongly against artefactual proteolysis of p68 because the sample preparation for this assay instantaneously inactivates exogenously added proteases such as trypsin and staphylococcal V8 protease. A previous report has shown that an abundant infected cell protein of estimated Mr 65 000 has additional, more rapidly migrating forms of 53 000 and 50 000 within infected cells (Pereira et al., 1984) . Although we have not definitely identified the p68 as this previously described infected cell protein, its abundance as well as its intracellular forms would suggest it is likely to be the same protein identified by these investigators. Our findings cannot discriminate between the possibilities that these intracellular forms represented degradation products or processed forms of the p68. Because only the p68 was found within Immunoblot analysisofsera from mice immunized with purified p68. Extracellular virionswere subjected to SDS-PAGE and transferred to nitrocellulose membranes. The strips were incubated with (lane 1) antibody 48 which is reactive with Friend murine leukaemia virus (Chesebro et al., 1981) , mouse sera I to 4 (lanes 2 to 5) diluted 1/100 and antibody 28-19 (lane 6). Specific binding was detected with a 1-'SI-labelled anti-mouse IgG.
mature extracellular virions, we favour the explanation that the p52-50 arose by degradation of the p68. Several findings in our studies suggested either directly or indirectly that the p68 and its intracellular forms were non-glycosylated. We failed to detect incorporation of several radiolabelled sugars into p68 even under conditions which readily labelled known CMVencoded glycoproteins. Although it was possible that the p68 contained trace amounts of carbohydrates, we could not demonstrate incorporation of [3H]glucosamine even with exposures of fluorograms exceeding 3 months. Furthermore, we could not demonstrate alterations in the electrophoretic migration of p68 following incubation of infected cells with either monensin or tunicamycin. Because these compounds inhibit the normal glycosylation and/or glycolytic processing of glycoproteins with N-linked sugars, this finding suggested the p68 did not contain N-linked carbohydrates. In addition, we could not detect specific binding of 12SI-labeUed concanavalin A or wheat germ agglutinin to p68 immobilized on nitrocellulose membranes (data not shown). These results were in agreement with recent findings which failed to demonstrate significant glycosylation of the p68 (Benko & Gibson, 1986) . Taken together our results would strongly argue against the presence of carbohydrates on the p68; however, as noted previously our results cannot rule out the possibility that the p68 contained trace amounts of carbohydrates which we failed to detect. In contrast to our findings, several investigators have indicated that w.J. BRITT AND L. VUGLER an abundant CMV-encoded protein of Mr 64000 to 68000 was glycosylated and incorporated readily detectable amounts of radiolabelled sugars (Clark et al., 1984; Pereira et al., 1984 Pereira et al., , 1982 . Our results can be reconciled with these findings when the labelling conditions of these previous experiments are examined. In contrast to our short labelling periods (up to 8 h), these investigators labelled infected cells with radioactive sugars for as long as 48 h. In this prolonged labelling period, glucosamine incorporation could have been an artefact as a result of the reutilization of 3H (1,C) in the labelled sugar as an amino acid. We have explored this explanation by labelling infected cells for 24, 36 and 48 h with [3H]glucosamine and have noted an increasing but minimal amount of 3H incorporation into p68 as the labelling period increased. Thus, it would appear that as the labelling period was extended, increasing quantities of noncarbohydrate 3H was available for incorporation into p68. Additional studies will be necessary to confirm this explanation of these discrepant results.
Because we detected the synthesis of the p68 very early within the infectious cycle of CMV as well as in the presence of Ara-C, this protein was most likely the product of a delayed early or fl gene. This result was somewhat surprising as previous descriptions of the replicative cycle of other herpesviruses have suggested that structural proteins of the virion were in many cases the products of late genes (Honess & Roizman, 1974) . However, the expression of certain late genes of herpesviruses is not dependent on viral DNA replication, although their level of expression appears to increase following DNA replication (Honess & Roizman, 1974 , 1975 Godowski & Knipe, 1985) . Our results were in agreement with a recent report which demonstrated the presence of a 68 000 Mr (ICP27) protein in the early periods following infection of HF cells with CMV Towne strain (Geballe et al., 1986) . These authors detected ICP27 some 7 to 9 h postinfection following a cycloheximide block. Because it is likely that the p68 and ICP27 represent the same protein as both proteins are encoded by a sequence mapping between 0.51 and 0.53 map units, these studies would indicate that in contrast to other well studied structural proteins of CMV, the p68 was synthesized within hours following infection. Although the role of p68 and its intracellular forms in the replicative cycle of CMV are unknown, their early synthesis and nuclear location within infected cells suggested they may play an important regulatory role in addition to their importance in the structural integrity of the virion. Interestingly, a virion tegument herpes simplex virus protein VP65 has been shown to be involved in the initiation of immediate early gene transcription (Campbell et al., 1984) . Because the CMV p68 is located within the tegument region and has protein kinase activity similar to that associated with tegument protein(s) of herpes simplex virus (Lemaster & Roizman, 1980) , it is tempting to speculate that the CMV p68 may play a similar role in the initiation of CMV transcription.
Several characteristics of the p68 suggested this CMV-encoded protein would be an ideal candidate for a subunit vaccine. The protein is immunogenic in man, synthesized prior to viral DNA replication and can be readily isolated in significant quantities. In addition, the genetic sequence encoding the p68 has been identified (Ruger et al., 1987) . However, our results suggested this protein was not expressed on the surface of infected cells or infectious virions. Thus, it seems unlikely that even a potent immunological response against the p68 could successfully eliminate either infectious virions or infected cells. An efficacious CMV subunit vaccine will probably include surface exposed CMV-encoded proteins such as the gp55-116 complex (Britt & Auger, 1986a) and/or the p62 (Britt & Auger, 1985) .
